Literature DB >> 18242514

GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model.

Hosein Kouros-Mehr1, Seth K Bechis, Euan M Slorach, Laurie E Littlepage, Mikala Egeblad, Andrew J Ewald, Sung-Yun Pai, I-Cheng Ho, Zena Werb.   

Abstract

How breast cancers are able to disseminate and metastasize is poorly understood. Using a hyperplasia transplant system, we show that tumor dissemination and metastasis occur in discrete steps during tumor progression. Bioinformatic analysis revealed that loss of the transcription factor GATA-3 marked progression from adenoma to early carcinoma and onset of tumor dissemination. Restoration of GATA-3 in late carcinomas induced tumor differentiation and suppressed tumor dissemination. Targeted deletion of GATA-3 in early tumors led to apoptosis of differentiated cells, indicating that its loss is not sufficient for malignant conversion. Rather, malignant progression occurred with an expanding GATA-3-negative tumor cell population. These data indicate that GATA-3 regulates tumor differentiation and suppresses tumor dissemination in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242514      PMCID: PMC2262951          DOI: 10.1016/j.ccr.2008.01.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  47 in total

1.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.

Authors:  M Frommer; L E McDonald; D S Millar; C M Collis; F Watt; G W Grigg; P L Molloy; C L Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

2.  All-trans-retinoic acid in acute promyelocytic leukemia.

Authors:  M S Tallman; J W Andersen; C A Schiffer; F R Appelbaum; J H Feusner; A Ogden; L Shepherd; C Willman; C D Bloomfield; J M Rowe; P H Wiernik
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

3.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

Authors:  Yixin Wang; Jan G M Klijn; Yi Zhang; Anieta M Sieuwerts; Maxime P Look; Fei Yang; Dmitri Talantov; Mieke Timmermans; Marion E Meijer-van Gelder; Jack Yu; Tim Jatkoe; Els M J J Berns; David Atkins; John A Foekens
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

4.  GATA-3 is expressed in association with estrogen receptor in breast cancer.

Authors:  R V Hoch; D A Thompson; R J Baker; R J Weigel
Journal:  Int J Cancer       Date:  1999-04-20       Impact factor: 7.396

5.  MET and MYC cooperate in mammary tumorigenesis.

Authors:  Alana L Welm; Suwon Kim; Bryan E Welm; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-28       Impact factor: 11.205

6.  Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.

Authors:  Jocelyne Jacquemier; Christophe Ginestier; Jacques Rougemont; Valérie-Jeanne Bardou; Emmanuelle Charafe-Jauffret; Jeannine Geneix; José Adélaïde; Alane Koki; Gilles Houvenaeghel; Jacques Hassoun; Dominique Maraninchi; Patrice Viens; Daniel Birnbaum; François Bertucci
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

7.  Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.

Authors:  L Van Parijs; Y Refaeli; J D Lord; B H Nelson; A K Abbas; D Baltimore
Journal:  Immunity       Date:  1999-09       Impact factor: 31.745

8.  Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target.

Authors:  J L Jakubczak; G Merlino; J E French; W J Muller; B Paul; S Adhya; S Garges
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

9.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

10.  Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years.

Authors:  H J BLOOM; W W RICHARDSON
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

View more
  184 in total

Review 1.  Murine mammary epithelial stem cells: discovery, function, and current status.

Authors:  Jane E Visvader; Gilbert H Smith
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 2.  The difficulty of targeting cancer stem cell niches.

Authors:  Mark A LaBarge
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Authors:  Marie-Liesse Asselin-Labat; Kate D Sutherland; François Vaillant; David E Gyorki; Di Wu; Sheridan Holroyd; Kelsey Breslin; Teresa Ward; Wei Shi; Mary L Bath; Siddhartha Deb; Stephen B Fox; Gordon K Smyth; Geoffrey J Lindeman; Jane E Visvader
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 4.  Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells.

Authors:  Gaoliang Ouyang; Zhe Wang; Xiaoguang Fang; Jia Liu; Chaoyong James Yang
Journal:  Cell Mol Life Sci       Date:  2010-03-18       Impact factor: 9.261

Review 5.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

Review 6.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

7.  Dynamic, long-term in vivo imaging of tumor-stroma interactions in mouse models of breast cancer using spinning-disk confocal microscopy.

Authors:  Andrew J Ewald; Zena Werb; Mikala Egeblad
Journal:  Cold Spring Harb Protoc       Date:  2011-02-01

8.  Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.

Authors:  Huaping Fan; Xiaofeng Zhao; Shaogang Sun; Ming Luo; Jun-Lin Guan
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

9.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.

Authors:  Ming Luo; Huaping Fan; Tamas Nagy; Huijun Wei; Chenran Wang; Suling Liu; Max S Wicha; Jun-Lin Guan
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

10.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling.

Authors:  Yuliya Pylayeva; Kelly M Gillen; William Gerald; Hilary E Beggs; Louis F Reichardt; Filippo G Giancotti
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.